The medication varenicline (Champix (TM)) remains one of the most controversial and misunderstood medications for smoking cessation on the market today. Join a passionate and forthright John Serginson for this quick and informative session on research that proves the effectiveness of this medicine.
Educators John Serginson
John Serginson has been a Nurse Practitioner: respiratory care at the Caboolture Hospital since 2010. He completed his nurse practitioner master's degree at the University of Queensland (UQ) with clinical training at The Prince Charles Hospital. He is an adjunct lecturer in the UQ School of Nursing and Midwifery. With 29 years’ experience as a nurse (16 in respiratory care), his research interests include domiciliary oxygen, inhaled therapy and COPD models of care. See Educator Profile